ArkBio recibe la autorización de comercialización en China para Aizhida para el tratamiento del TDAH

📩 info@dengyuemed.com
🔗https://dengyuepharma.com

#ADHD #TDAH #ArkBio #Aizhida #NMPA #Biotecnología #IndustriaFarmacéutica #InnovaciónMédica #SaludInfantil

Ark Biopharmaceutical's Aizhida Approved in China for ADHD Treatment Ark Biopharmaceutical's new ADHD medication, Aizhida, has been approved in China, offering a unique dual mechanism for effective symptom control.

Ark Biopharmaceutical's Aizhida Approved in China for ADHD Treatment #China #Shanghai #ADHD #Ark_Biopharmaceutical #Aizhida